Pathological re-evaluation confirmed a Ki-67 ≤ 55% in 30 patients, while seven patients had Ki-67 > 55%, among them 4 NEC, 2 NET G3 and one case of MiNEN. This evidence concerns the gene MKI67 and neuroendocrine carcinoma.